(Q37876231)

24 August 2017

1 reference

title

New antifungal agents for the systemic mycoses (English)

1 reference

24 August 2017

Ringel SM

1

1 reference

24 August 2017

publication date

1 February 1990

1 reference

24 August 2017

number of pages

13

1 reference

inferred from page(s)

published in

Mycopathologia

1 reference

24 August 2017

volume

109

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

75-87

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00436788

24 August 2017

exact match

0 references

cites work

Influence of food on the pharmacokinetics of ketoconazole

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Overview of medically important antifungal azole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Antifungal susceptibility tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Fluconazole and testosterone: in vivo and in vitro studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Comparison of fluconazole and amphotericin B in treating histoplasmosis in immunosuppressed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Oral therapy for experimental coccidioidomycosis with R41 400 (ketoconazole), a new imidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Pharmacokinetics of ketoconazole in patients with neoplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Ketoconazole Blocks Adrenal Steroid Synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

In vitro and in vivo studies of ambruticin (W7783): new class of antifungal antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Azole antifungal agents: emphasis on new triazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

In vitro studies with ambruticin, a new antifungal antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00436788

Oral treatment of paracoccidioidomycosis and histoplasmosis with itraconazole in humans

21 January 2018

1 reference

12 December 2020

Therapeutic Properties of Oral Ambruticin (W7783) in Experimental Pulmonary Coccidioidomycosis of Mice

1 reference

12 December 2020

Persistent adrenal insufficiency secondary to low-dose ketoconazole therapy.

1 reference

12 December 2020

Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study

1 reference

12 December 2020

Treatment of blastomycosis and histoplasmosis with ketoconazole. Results of a prospective randomized clinical trial. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results

1 reference

12 December 2020

Development of amphotericin B liposomes bearing antibody specific to Candida albicans

1 reference

12 December 2020

Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective, randomized, controlled, double-blind study

1 reference

12 December 2020

Ketoconazole Blocks Testosterone Synthesis

1 reference

12 December 2020

Disposition of ketoconazole, an oral antifungal, in humans

1 reference

12 December 2020

Itraconazole in the treatment of paracoccidioidomycosis: a preliminary report

1 reference

12 December 2020

A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis

1 reference

12 December 2020

Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients

1 reference

12 December 2020

Itraconazole for deep mycoses: preliminary experience in Mexico

1 reference

12 December 2020

Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion

1 reference

12 December 2020

Ketoconazole effects on methylprednisolone disposition and their joint suppression of endogenous cortisol

1 reference

12 December 2020

Effect of ketoconazole on hepatic oxidative drug metabolism

1 reference

12 December 2020

Tolerance to and efficacy of itraconazole in treatment of systemic mycoses: preliminary results

1 reference

12 December 2020

High-Dose Ketoconazole Therapy and Adrenal and Testicular Function in Humans

1 reference

12 December 2020

Hepatic reactions associated with ketoconazole in the United Kingdom

1 reference

12 December 2020

Modulation of immune reactivity by phenylimidothiazole salts in mice immunized by sheep red blood cells

1 reference

12 December 2020

Systemic mycoses in the United States, 1980-1982

1 reference

12 December 2020

1 reference

12 December 2020

Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis

1 reference

12 December 2020

Initial experience in therapy for progressive mycoses with itraconazole, the first clinically studied triazole

1 reference

12 December 2020

Ambruticin (W7783), a new antifungal antibiotic

1 reference

12 December 2020

Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00436788

1 reference

24 August 2017

1 reference